For the 5-fluorouracil group , median survival was 25.6 ( 95 % CI = 20.1 to 27.9 ) and 21.9 ( 95 % CI = 16.0 to 28.3 ) months for those with low and high hENT1 expression , respectively ( ( 2 ) = 0.83 ; P = .36 ) .